Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
Conditions: Critical Illness; New Onset Atrial Fibrillation Interventions: Drug: Magnesium sulfate; Drug: Placebo Sponsors: Queen's University; Southeastern Ontario Academic Medical Organization (SEAMO) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials